美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Nasus Pharma Ltd.

3.59

-0.0600-1.64%

盤後：3.590.00000.00%19:30 EDT

成交量：1.84萬

成交額：6.51萬

市值：4,221.45萬

市盈率：-3.36

高：3.77

開：3.62

低：3.45

收：3.65

52周最高：9.50

52周最低：1.98

股本：1,175.89萬

流通股本：621.40萬

量比：1.87

換手率：0.30%

股息：- -

股息率：- -

每股收益(TTM):-1.0691

每股收益(LYR):-0.7311

淨資產收益率：-316.04%

總資產收益率：-96.73%

市淨率：3.84

市盈率(LYR):-4.91

資料載入中...

總覽公司新聞資訊公告

Nasus Pharma宣佈FDA批准啓動Ns002治療過敏性休克臨床研究

納斯製藥任命資深藥企高管 Brendan P. O'Grady 為首席執行官，引領戰略增長

納斯製藥任命醫藥行業資深人士Brendan P. O'Grady為首席執行官，引領戰略增長

Nasus Pharma公布鼻內給藥昂丹司瓊（Ns003）臨床前藥代動力學與安全性研究積極結果

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/NSRX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NSRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NSRX\",,,,,undefined,":{"symbol":"NSRX","market":"US","secType":"STK","nameCN":"Nasus Pharma Ltd.","latestPrice":3.59,"timestamp":1789502400000,"preClose":3.65,"halted":0,"volume":18441,"hourTrading":{"tag":"盘后","latestPrice":3.59,"preClose":3.59,"latestTime":"19:30 EDT","volume":9,"amount":32.03,"timestamp":1789515005622,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.016438356164383577,"floatShares":6214000,"shares":11758900,"eps":-1.06915,"marketStatus":"未開盤","change":-0.06,"latestTime":"09-15 16:00:00 EDT","open":3.62,"high":3.7665,"low":3.45,"amount":65083.52993220001,"amplitude":0.086712,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.06915,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"listingDate":1755057600000,"exchange":"AMEX","adjPreClose":3.65,"preHourTrading":{"tag":"盘前","latestPrice":3.65,"preClose":3.65,"latestTime":"04:00 EDT","volume":4,"amount":14.6,"timestamp":1789459205434,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":3.59,"preClose":3.59,"latestTime":"19:30 EDT","volume":9,"amount":32.03,"timestamp":1789515005622,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.8734},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NSRX\",,,,,undefined,":{"symbol":"NSRX","floatShares":6214000,"roa":"-96.73%","roe":"-316.04%","lyrEps":-0.731074,"volumeRatio":1.8734,"shares":11758900,"dividePrice":0,"high":3.7665,"amplitude":0.086712,"preClose":3.65,"low":3.45,"week52Low":1.98,"pbRate":"3.84","week52High":9.5,"institutionHeld":0,"latestPrice":3.59,"eps":-1.06915,"divideRate":0,"volume":18441,"delay":0,"ttmEps":-1.06915,"open":3.62,"prevYearClose":9.15,"prevWeekClose":3.4049,"prevMonthClose":4.084,"prevQuarterClose":3.5,"fiveDayClose":3.88,"twentyDayClose":3.7,"sixtyDayClose":3.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NSRX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NSRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NSRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1766116800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NSRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NSRX","date":"2026-09-14","current":-3.357808,"percent":0.996296,"low":-51.389177,"twenty":-44.647674,"median":-28.143319,"eighty":-5.859404,"high":-3.720961,"avg":-24.548076,"sd":17.679308,"marketCap":39883876},"quantilePoints":[{"date":"2025-08-15","current":-47.343663,"twenty":-48.284655,"median":-47.931783,"eighty":-47.578911,"marketCap":72530491},{"date":"2025-08-22","current":-50.265593,"twenty":-50.691372,"median":-49.082873,"eighty":-48.024103,"marketCap":77006889},{"date":"2025-08-29","current":-47.604473,"twenty":-50.029049,"median":-48.047994,"eighty":-47.509856,"marketCap":72930053},{"date":"2025-09-05","current":-47.370886,"twenty":-49.082873,"median":-47.841017,"eighty":-47.486202,"marketCap":72572198},{"date":"2025-09-12","current":-48.136697,"twenty":-48.519903,"median":-47.66361,"eighty":-47.343663,"marketCap":73745420},{"date":"2025-09-19","current":-47.384488,"twenty":-48.195834,"median":-47.722745,"eighty":-47.36793,"marketCap":72593035},{"date":"2025-09-26","current":-47.604473,"twenty":-48.136697,"median":-47.604473,"eighty":-47.343663,"marketCap":72930053},{"date":"2025-10-03","current":-36.900859,"twenty":-48.077561,"median":-47.51577,"eighty":-47.308794,"marketCap":56532116},{"date":"2025-10-10","current":-45.830394,"twenty":-48.047993,"median":-47.384488,"eighty":-45.830394,"marketCap":70212163},{"date":"2025-10-17","current":-46.835706,"twenty":-47.900153,"median":-47.36793,"eighty":-45.534713,"marketCap":71752301},{"date":"2025-10-24","current":-44.943354,"twenty":-47.900153,"median":-47.314116,"eighty":-44.943354,"marketCap":68853218},{"date":"2025-10-31","current":-46.007802,"twenty":-47.900153,"median":-47.308794,"eighty":-45.239034,"marketCap":70483952},{"date":"2025-11-07","current":-44.647674,"twenty":-47.781881,"median":-47.308794,"eighty":-44.943354,"marketCap":68400236},{"date":"2025-11-14","current":-46.717433,"twenty":-47.722745,"median":-47.22009,"eighty":-44.647674,"marketCap":71571108},{"date":"2025-11-21","current":-41.395195,"twenty":-47.722745,"median":-46.835706,"eighty":-44.351994,"marketCap":63417438},{"date":"2025-11-28","current":-41.395195,"twenty":-47.675437,"median":-46.717433,"eighty":-43.654189,"marketCap":63417438},{"date":"2025-12-05","current":-40.508154,"twenty":-47.6163,"median":-46.155642,"eighty":-42.826285,"marketCap":62058492},{"date":"2025-12-12","current":-38.438395,"twenty":-47.604473,"median":-45.830394,"eighty":-41.395195,"marketCap":58887621},{"date":"2025-12-19","current":-37.669627,"twenty":-47.557164,"median":-45.682553,"eighty":-41.383368,"marketCap":57709868},{"date":"2025-12-26","current":-44.351994,"twenty":-47.509856,"median":-45.298465,"eighty":-41.395195,"marketCap":67947255},{"date":"2026-01-02","current":-43.332802,"twenty":-47.445516,"median":-44.987706,"eighty":-41.359713,"marketCap":82895651},{"date":"2026-01-09","current":-33.62436,"twenty":-47.384488,"median":-44.884218,"eighty":-40.236129,"marketCap":64323401},{"date":"2026-01-16","current":-33.62436,"twenty":-47.379047,"median":-44.647674,"eighty":-40.035066,"marketCap":64323401},{"date":"2026-01-23","current":-31.392839,"twenty":-47.370295,"median":-44.529402,"eighty":-38.570149,"marketCap":60054501},{"date":"2026-01-30","current":-26.473264,"twenty":-47.36793,"median":-44.351994,"eighty":-37.823381,"marketCap":50643354},{"date":"2026-02-06","current":-27.467787,"twenty":-47.363077,"median":-44.351994,"eighty":-35.774424,"marketCap":52545877},{"date":"2026-02-13","current":-34.411045,"twenty":-47.337754,"median":-43.81977,"eighty":-34.753161,"marketCap":65828330},{"date":"2026-02-20","current":-30.724148,"twenty":-47.314116,"median":-43.332802,"eighty":-34.411045,"marketCap":58775295},{"date":"2026-02-27","current":-31.33863,"twenty":-47.308794,"median":-42.873594,"eighty":-33.62436,"marketCap":59950800},{"date":"2026-03-06","current":-30.662699,"twenty":-47.308794,"median":-41.857638,"eighty":-33.151251,"marketCap":58657744},{"date":"2026-03-13","current":-28.389112,"twenty":-47.308794,"median":-41.483899,"eighty":-32.108896,"marketCap":54308372},{"date":"2026-03-20","current":-15.239177,"twenty":-47.308794,"median":-41.395195,"eighty":-31.096524,"marketCap":29152546},{"date":"2026-03-27","current":-4.817647,"twenty":-47.249657,"median":-41.365627,"eighty":-30.724148,"marketCap":28212141},{"date":"2026-04-02","current":-5.099481,"twenty":-47.249657,"median":-40.41945,"eighty":-29.587069,"marketCap":29862560},{"date":"2026-04-10","current":-4.639528,"twenty":-47.202349,"median":-40.212475,"eighty":-29.052754,"marketCap":27169074},{"date":"2026-04-17","current":-4.499542,"twenty":-47.048596,"median":-40.212475,"eighty":-28.102929,"marketCap":26349318},{"date":"2026-04-24","current":-6.799308,"twenty":-46.871188,"median":-39.325435,"eighty":-27.041563,"marketCap":39816747},{"date":"2026-05-01","current":-5.39945,"twenty":-46.741088,"median":-38.438986,"eighty":-25.76289,"marketCap":31619181},{"date":"2026-05-08","current":-6.77931,"twenty":-46.717433,"median":-38.438395,"eighty":-18.667992,"marketCap":39699639},{"date":"2026-05-15","current":-5.939395,"twenty":-46.670125,"median":-36.896469,"eighty":-15.349784,"marketCap":34781099},{"date":"2026-05-22","current":-5.739416,"twenty":-46.374445,"median":-36.254495,"eighty":-7.119275,"marketCap":33610018},{"date":"2026-05-29","current":-6.399349,"twenty":-46.126074,"median":-35.850198,"eighty":-6.399349,"marketCap":37474585},{"date":"2026-06-05","current":-6.47934,"twenty":-46.007802,"median":-35.518691,"eighty":-6.399349,"marketCap":37943017},{"date":"2026-06-12","current":-6.339355,"twenty":-45.901357,"median":-34.571052,"eighty":-6.29136,"marketCap":37123261},{"date":"2026-06-18","current":-6.159373,"twenty":-45.830394,"median":-34.411045,"eighty":-6.175371,"marketCap":36069288},{"date":"2026-06-26","current":-6.599328,"twenty":-45.830394,"median":-33.62436,"eighty":-6.175371,"marketCap":38645666},{"date":"2026-07-02","current":-7.029284,"twenty":-45.771258,"median":-33.505965,"eighty":-6.207368,"marketCap":41163490},{"date":"2026-07-10","current":-6.019387,"twenty":-45.49935,"median":-32.81339,"eighty":-6.167372,"marketCap":35249532},{"date":"2026-07-17","current":-6.139375,"twenty":-45.334124,"median":-32.21535,"eighty":-6.139375,"marketCap":35952180},{"date":"2026-07-24","current":-6.18537,"twenty":-45.191725,"median":-31.392839,"eighty":-6.099379,"marketCap":36221529},{"date":"2026-07-31","current":-6.359353,"twenty":-45.00249,"median":-31.096524,"eighty":-6.099379,"marketCap":37240369},{"date":"2026-08-07","current":-6.77931,"twenty":-44.972922,"median":-30.724148,"eighty":-6.099379,"marketCap":39699639},{"date":"2026-08-14","current":-6.399349,"twenty":-44.943354,"median":-30.662699,"eighty":-6.099379,"marketCap":37474585},{"date":"2026-08-21","current":-4.275233,"twenty":-44.884218,"median":-29.56931,"eighty":-6.079381,"marketCap":45086610},{"date":"2026-08-28","current":-4.552846,"twenty":-44.798471,"median":-29.220042,"eighty":-6.059383,"marketCap":48014312},{"date":"2026-09-04","current":-4.164188,"twenty":-44.647674,"median":-28.450561,"eighty":-6.019387,"marketCap":43915530},{"date":"2026-09-11","current":-3.720961,"twenty":-44.647674,"median":-28.266216,"eighty":-5.923397,"marketCap":39241256},{"date":"2026-09-14","current":-3.781896,"twenty":-44.647674,"median":-28.143319,"eighty":-5.859404,"marketCap":39883876}],"updateTime":1789543778311},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NSRX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1140248896","title":"Nasus Pharma宣佈FDA批准啓動Ns002治療過敏性休克臨床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1140248896","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140248896?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 20:01","pubTimestamp":1789387282,"startTime":"0","endTime":"0","summary":"Nasus Pharma Ltd.（纳斯达克代码：NSRX）今日宣布，美国食品药品监督管理局（FDA）已批准其新药临床试验申请（IND），准许公司启动Ns002用于治疗过敏性休克的临床研究。这一里程碑式的进展，标志着该候选药物正式迈入临床开发阶段，为严重过敏反应患者带来了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NSRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197206772","title":"納斯製藥任命資深藥企高管 Brendan P. O'Grady 為首席執行官，引領戰略增長","url":"https://stock-news.laohu8.com/highlight/detail?id=1197206772","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197206772?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 19:35","pubTimestamp":1785238543,"startTime":"0","endTime":"0","summary":"以色列特拉维夫，2026年7月28日——纳斯制药有限公司是一家专注于创新鼻内产品开发的临床阶段制药公司。今日，该公司宣布任命药界资深人士 Brendan P. O'Grady 为其新任首席执行官。O'Grady 先生将引领公司迈入下一增长阶段，其首要任务是释放 NS002 的商业潜力，推进公司产品管线及业务发展计划，并最大化其专有 Nasax 鼻内给药技术平台的价值。此次领导层交接已于2026年7月27日生效，O'Grady 先生接替 Dan Teleman 的职务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NSRX","DBB","BK4232","R","BK4007","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129096284","title":"納斯製藥任命醫藥行業資深人士Brendan P. O'Grady為首席執行官，引領戰略增長","url":"https://stock-news.laohu8.com/highlight/detail?id=1129096284","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129096284?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 19:31","pubTimestamp":1785238273,"startTime":"0","endTime":"0","summary":"纳斯制药（Nasus Pharma Ltd.）近日宣布，任命医药行业资深高管Brendan P. O'Grady为公司新任首席执行官。这一关键人事变动，旨在推动企业的战略扩张与未来发展。O'Grady先生将全面负责公司的运营管理，并主导实施其长期增长战略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NSRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138787740","title":"Nasus Pharma公布鼻內給藥昂丹司瓊（Ns003）臨床前藥代動力學與安全性研究積極結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1138787740","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138787740?lang=zh_tw&edition=fundamental","pubTime":"2026-06-09 20:00","pubTimestamp":1781006426,"startTime":"0","endTime":"0","summary":"Nasus Pharma Ltd. 近日宣布，其研发的鼻内给药昂丹司琼（Ns003）在临床前药代动力学与安全性研究中取得了积极成果。该研究数据表明，Ns003在实验模型中展现出良好的药代动力学特征与耐受性，为后续的临床开发奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NSRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}